Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Cook

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Cell Cycle (Georgetown, Tex.)|September 21, 2007
Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repelsKatherine E Ewings, Ceri M Wiggins, Simon J Cook
Biochemical Society Transactions|July 19, 2013
Adaptation to chronic mTOR inhibition in cancer and in agingRebecca Gilley, Kathryn Balmanno, Claire L Cope, et al.
Plos One|October 15, 2013
MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signalingCatherine Evans, Simon J Cook, Michael P Coleman, et al.
Plos One|August 29, 2022
Assessment of climate change effects on vegetation and river hydrology in a semi-arid river basinJamal Hassan Ougahi, Mark E J Cutler, Simon J Cook
The FEBS Journal|May 27, 2017
Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signallingSimon J Cook, Kate Stuart, Rebecca Gilley, et al.
Trends in Cell Biology|December 4, 2020
CDK1, the Other 'Master Regulator' of AutophagyRichard I Odle, Oliver Florey, Nicholas T Ktistakis, et al.
The Journal of Biological Chemistry|March 21, 2003
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, BimRebecca Ley, Kathryn Balmanno, Kathryn Hadfield, et al.
Cellular Signalling|July 31, 2008
ERK1/2 and p38 cooperate to delay progression through G1 by promoting cyclin D1 protein turnoverRuth M Densham, Daniel E Todd, Kathy Balmanno, et al.
The Biochemical Journal|July 8, 2003
Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1Claire J Chalmers, Kathryn Balmanno, Kathryn Hadfield, et al.
Nature Reviews. Cancer|September 25, 2015
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding roadChristopher J Caunt, Matthew J Sale, Paul D Smith, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Cell Cycle (Georgetown, Tex.)|September 21, 2007
Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repelsKatherine E Ewings, Ceri M Wiggins, Simon J Cook
Biochemical Society Transactions|July 19, 2013
Adaptation to chronic mTOR inhibition in cancer and in agingRebecca Gilley, Kathryn Balmanno, Claire L Cope, et al.
Plos One|October 15, 2013
MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signalingCatherine Evans, Simon J Cook, Michael P Coleman, et al.
Plos One|August 29, 2022
Assessment of climate change effects on vegetation and river hydrology in a semi-arid river basinJamal Hassan Ougahi, Mark E J Cutler, Simon J Cook
The FEBS Journal|May 27, 2017
Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signallingSimon J Cook, Kate Stuart, Rebecca Gilley, et al.
Trends in Cell Biology|December 4, 2020
CDK1, the Other 'Master Regulator' of AutophagyRichard I Odle, Oliver Florey, Nicholas T Ktistakis, et al.
The Journal of Biological Chemistry|March 21, 2003
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, BimRebecca Ley, Kathryn Balmanno, Kathryn Hadfield, et al.
Cellular Signalling|July 31, 2008
ERK1/2 and p38 cooperate to delay progression through G1 by promoting cyclin D1 protein turnoverRuth M Densham, Daniel E Todd, Kathy Balmanno, et al.
The Biochemical Journal|July 8, 2003
Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1Claire J Chalmers, Kathryn Balmanno, Kathryn Hadfield, et al.
Nature Reviews. Cancer|September 25, 2015
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding roadChristopher J Caunt, Matthew J Sale, Paul D Smith, et al.
Pageof 10